D D Richman

发表

Sequence clusters in human immunodeficiency virus type 1 reverse transcriptase are associated with subsequent virological response to antiretroviral therapy.

D. Richman, H. Günthard, V. Johnson, 1999, The Journal of infectious diseases.

Temporal gene regulation during HIV-1 infection of human CD4+ T cells.

L Leoni, J. Corbeil, J. Welsh, 2001, Genome research.

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy.

D. Richman, B. Larder, G. Darby, 1989, Science.

The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression.

D. Richman, S. Bozzette, D D Richman, 1994, The Journal of infectious diseases.

Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study Group.

T Creagh-Kirk, R. Chaisson, D. Richman, 1991, JAMA.

Drug resistance in viruses.

D. Richman, D D Richman, 1994, Trends in microbiology.

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.

D. Richman, H. Günthard, D. Havlir, 1997, Science.

Nevirapine-resistant human immunodeficiency virus: kinetics of replication and estimated prevalence in untreated patients

D. Richman, A. Gamst, D. Havlir, 1996, Journal of virology.

Normal physiology and HIV pathophysiology of human T-cell dynamics.

D D Richman, 2000, The Journal of clinical investigation.

Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy.

R. Haubrich, D. Richman, H. Günthard, 2000, The Journal of infectious diseases.

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.

R Brookmeyer, R. Siliciano, J. Margolick, 1997, Science.

Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years.

D. Richman, H. Günthard, S. Frost, 2001, The Journal of infectious diseases.

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.

E A Emini, D. Richman, D. Havlir, 1997, The New England journal of medicine.

Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy

J. Corbeil, D. Richman, D. Havlir, 1994, Journal of virology.

Zidovudine resistance of human immunodeficiency virus.

D. Richman, D D Richman, 1990, Reviews of infectious diseases.

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.

M A Fischl, M. Hirsch, D. Richman, 1987, The New England journal of medicine.

Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro.

D. Richman, C. Spina, H. Prince, 1997, The Journal of clinical investigation.

Prevalence and predictive value of intermittent viremia with combination hiv therapy.

M. Hirsch, D. Richman, H. Günthard, 2001, JAMA.

Isothermal, in vitro amplification of nucleic acids by a multienzyme reaction modeled after retroviral replication.

D. Richman, T. Gingeras, J. Guatelli, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.

B Clotet, S. Hammer, M. Hirsch, 1998, JAMA.

Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells.

D. Richman, S. Little, Steven Wolinsky, 1999, Science.

Spatiotemporal dynamics of HIV propagation.

D. Richman, J. Wong, M. Strain, 2002, Journal of theoretical biology.

CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive beta-chemokines.

D. Richman, R. Kornbluth, D D Richman, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Isothermal, in vitro amplification of nucleic acids by a multienzyme reaction modeled after retroviral replication.

D. Richman, T. Gingeras, J. Guatelli, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Antiretroviral Therapy in Adults Updated Recommendations of the International AIDS Society–USA Panel

M A Fischl, B G Gazzard, S. Hammer, 2000 .

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.

M A Fischl, R. Schooley, D. Richman, 1987, The New England journal of medicine.

Natural history of advanced HIV disease in patients treated with zidovudine. The Zidovudine Epidemiology Study Group.

T Creagh-Kirk, R. Chaisson, D. Richman, 1992, AIDS.

Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist.

D. Richman, L. Slice, A. Schutt, 1991, Science.

In vitro Anti-HIV-1 Activity of sn-2-Substituted 1-O-Octadecyl-sn-Glycero-3-Phosphonoformate Analogues and Synergy with Zidovudine

D. Richman, T. Chou, J. Mellors, 2000, Antiviral chemistry & chemotherapy.

Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complex.

I Grant, J H Atkinson, A. Wu, 1990, Journal of acquired immune deficiency syndromes.

Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens.

M. Hirsch, D. Richman, C. Petropoulos, 2000, JAMA.

Incidence and impact of resistance against approved antiretroviral drugs

D. Richman, D. Pillay, S. Taylor, 2000, Reviews in medical virology.